020 - New Medicare Hearing Benefit and FDA's Proposed OTC Hearing Aid Regulations - Industry Perspective with Brandon Sawalich episode artwork

EPISODE · Nov 8, 2021 · 26 MIN

020 - New Medicare Hearing Benefit and FDA's Proposed OTC Hearing Aid Regulations - Industry Perspective with Brandon Sawalich

from This Week in Hearing · host This Week in Hearing

Brandon Sawalich, President and CEO of Starkey, returns to discuss the recently released FDA proposed rule for Over The Counter (OTC) hearing aids, as well as the new Medicare Hearing Benefit currently under consideration in Congress as part of a larger spending package. In its current form, the Medicare benefit includes a provision to provide hearing aid coverage for those with severe hearing loss every 5 years.    The pair discuss the implications of both the draft OTC rule, as well as the Medicare benefit, on patients, providers and the overall industry. Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter: https://www.youtube.com/c/ThisWeekinHearing https://www.linkedin.com/company/this-week-in-hearing/  https://twitter.com/WeekinHearing  

Episode metadata supplied by the publisher feed · Published Nov 8, 2021

Embed this episode

NOW PLAYING

020 - New Medicare Hearing Benefit and FDA's Proposed OTC Hearing Aid Regulations - Industry Perspective with Brandon Sawalich

0:00 26:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Week in Hearing?

This episode is 26 minutes long.

When was this This Week in Hearing episode published?

This episode was published on November 8, 2021.

Can I download this This Week in Hearing episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!